RAPT Stock Analysis: Buy, Sell, or Hold?
RAPT - RAPT Therapeutics, Inc. Common Stock
$58.02
0.04 (0.07%)
▲
5d:
+0.16%
30d:
+0.68%
90d:
+74.44%
HOLD
MODERATE Confidence
Analysis Updated: Mar 2, 2026 12:00 AM ET
Earnings: Mar 05, 2026
0d
Get Alerted When RAPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RAPT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RAPT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RAPT is currently trading at $58.02, which is considered extended relative to its 30-day fair value range of $57.92 to $57.99.
Technical Outlook: Technically, RAPT is in a strong uptrend. The price is currently testing key support at $57.72. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RAPT is in a strong uptrend. The price is currently testing key support at $57.72. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$57.92 -
$57.99
Company Quality Score
53/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
52.9%
Protect Your Profits
RAPT is technically overbought (RSI 80). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- NEUTRAL: Near Wall St target ($58.00)
Fair Price Analysis
30-Day Fair Range
$57.92 -
$57.99
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$2.03
(3.5%)
Support & Resistance Levels
Support Level
$57.72
Resistance Level
$58.01
Current Trend
Strong Uptrend
Technical data as of
Mar 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-18.69
Wall Street Target
$58.00
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: March 31, 2026 8:29 AM ET
Data refreshes hourly during market hours. Next update: 9:29 AM
Data refreshes hourly during market hours. Next update: 9:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RAPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 56 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 63 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 45 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$26 | 54 HOLD |
Advanced RAPT Option Strategies
Professional options setups generated by AI based on today's RAPT price and gamma walls.
